See results for patients treated with TEPEZZA in clinical trials



Baseline3
Proptosis: 24 mm
Diplopia: 0
Clinical Activity Score (CAS): 5
Inflammatory signs and symptoms
- Eyelid swelling
- Eyelid erythema
- Conjunctival redness
- Chemosis
- Inflammation of caruncle/plica



Post-Treatment (Week 24)3
Proptosis: 19 mm
Diplopia: 0
CAS: 1
Inflammatory signs and symptoms
- Eyelid swelling



Baseline4
Proptosis: 25 mm
Diplopia: 3
CAS: 5
Inflammatory signs and symptoms
- Spontaneous orbital pain
- Gaze-evoked orbital pain
- Eyelid swelling
- Eyelid erythema
- Conjunctival redness



Post-Treatment (Week 24)4
Proptosis: 21 mm
Diplopia: 0
CAS: 0
Inflammatory signs and symptoms
- No inflammatory signs and symptoms



Baseline4
Proptosis: 25 mm
Diplopia: 3
CAS: 5
Inflammatory signs and symptoms
- Spontaneous orbital pain
- Gaze-evoked orbital pain
- Eyelid swelling
- Eyelid erythema
- Conjunctival redness



Post-Treatment (Week 24)4
Proptosis: 21 mm
Diplopia: 0
CAS: 0
Inflammatory signs and symptoms
- No inflammatory signs and symptoms
Patient treated with TEPEZZA in a clinical trial. Results shown are with no surgical intervention. Individual results may vary.